retatrutide type 2 diabetes phase 2 results 2024 2025 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released trial demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Weight loss with retatrutide as

A study in the Journal of Pharmaceutical and Biomedical Analysis found that semaglutide exposed to room temperature (25C) loses 10-15% potency per month compared to refrigerated storage

Despite media narratives that often frame GLP-1 drugs as empowering, over half of women (52%) and more than a third of men (37%) believe users are judged negatively, seen as taking the easy way out

P., Wu, Q., Du, Y., Gurbuz, S., & Hartman, M

GLP-1/GIP/Glucagon Triple Agonist Analog Molar Mass : 4,731.34 g/mol Storage Guidelines: Store sealed vials at ?4F (?20C) for up to 12 months

Some prefer morning injections to align with their routine

Around week 10 maybe